Ignite Creation Date:
2024-05-06 @ 3:07 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04520217
Status:
RECRUITING
Last Update Posted:
2024-03-04
First Post:
2020-08-17
Brief Title:
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
Sponsor:
Wright State University
Organization:
Wright State University
Study Overview
Official Title:
Pilot Studies Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is three-fold First researchers will assess whether subjects who have clinically abnormal reactions to sunlight photosensitivity have increased levels of microvesicle particles MVP following ultraviolet B UVB treatment to localized area of skin Second researchers will assess if topical application of the medicine imipramine will block UVB-induced MVP release Third researchers will assess if the topical cream will block UVB-induced increased erythema reactions reddening of the skin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None